SEC Company Response from Aura Biosciences, Inc. (AURA) (CIK 0001501796) (AURA) — Aug 18, 2026
Aura Biosciences, Inc. (AURA) (CIK 0001501796)
Date: Aug. 18, 2026 · CIK: 0001501796 · Accession: 0001193125-26-355417
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-298228
Letter
Re:
AURA BIOSCIENCES, INC. 80 Guest Street Boston, MA 02135 August 18, 2026 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549
Attention:
Office of Life Sciences
Aura Biosciences, Inc. Registration Statement on Form S-3 Filed August 11, 2026 File No. 333-298228 Requested Date: August 20, 2026 Requested Time: 4 p.m. Eastern Time Ladies and Gentlemen: Aura Biosciences, Inc. (the “ Registrant ”) hereby requests that the Securities and Exchange Commission (the “ Commission ”) take appropriate action to make the above-captioned Registration Statement on Form S - 3 effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes Ryan Mitteness or Chelsea Anderson, both of whom are attorneys with the Registrant’s outside legal counsel, Fenwick & West LLP, to orally modify or withdraw this request for acceleration. The Registrant requests that it be notified of such effectiveness by a telephone call to Mr. Mitteness at (206) 389-4533 or, in his absence, to Ms. Anderson at (206) 389-4516. * * *
Sincerely,
AURA BIOSCIENCES, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP AURA BIOSCIENCES, INC. 80 Guest Street Boston, MA 02135 August 18, 2026 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attention: Office of Life Sciences Re: Aura Biosciences, Inc. Registration Statement on Form S-3 Filed August 11, 2026 File No. 333-298228 Requested Date: August 20, 2026 Requested Time: 4 p.m. Eastern Time Ladies and Gentlemen: Aura Biosciences, Inc. (the “ Registrant ”) hereby requests that the Securities and Exchange Commission (the “ Commission ”) take appropriate action to make the above-captioned Registration Statement on Form S - 3 effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes Ryan Mitteness or Chelsea Anderson, both of whom are attorneys with the Registrant’s outside legal counsel, Fenwick & West LLP, to orally modify or withdraw this request for acceleration. The Registrant requests that it be notified of such effectiveness by a telephone call to Mr. Mitteness at (206) 389-4533 or, in his absence, to Ms. Anderson at (206) 389-4516. * * * Sincerely, AURA BIOSCIENCES, INC. By: /s/ Anthony Gibney Anthony Gibney Chief Financial Officer cc: Natalie Holles, Chief Executive Officer Aura Biosciences, Inc. Effie Toshav, Esq. Ryan Mitteness, Esq. Chelsea Anderson, Esq. Fenwick & West LLP [Signature Page to Company Acceleration Request Letter]